Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Sorry, but you all have to get the numbers right!!!!

Let's make this simple:

13-G/2006 = Appx. 38MM shares.

Consideration for allowing warrant buyback=7MM

Warrant buyback complete 10/02/07.

13-G/2007= Appx. 24MM shares.

21MM shares dumped on the backs of retail between the 13-G filings - 21MM shares!

 

Shares are shares and warrants are warrants. We shouldn't try to mix them up. It confuses everything!

Share
New Message
Please login to post a reply